$Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker$
Código QR

Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker

Kyung Jae Ryu,1 Seunghoon Kim,2 Mee Kum Kim,3 Hae Jung Paik,1 Dong Hyun Kim1 1Department of Ophthalmology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea; 2RudaCure Co., LTD, Incheon, Korea; 3Department of Ophthalmology, Seoul National University College of Medicine, Seoul...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ryu KJ, Kim S, Kim MK, Paik HJ, Kim DH
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	dry eye disease ocular surface inflammation tear mmp-9 positivity corticosteroid Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ca31216df33c41b39e8b182d6b17ba52
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ca31216df33c41b39e8b182d6b17ba52
record_format	dspace
spelling	oai:doaj.org-article:ca31216df33c41b39e8b182d6b17ba522021-12-02T14:29:25ZShort-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker1177-5483https://doaj.org/article/ca31216df33c41b39e8b182d6b17ba522021-02-01T00:00:00Zhttps://www.dovepress.com/short-term-therapeutic-effects-of-topical-corticosteroids-on-refractor-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Kyung Jae Ryu,1 Seunghoon Kim,2 Mee Kum Kim,3 Hae Jung Paik,1 Dong Hyun Kim1 1Department of Ophthalmology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea; 2RudaCure Co., LTD, Incheon, Korea; 3Department of Ophthalmology, Seoul National University College of Medicine, Seoul, KoreaCorrespondence: Dong Hyun KimDepartment of Ophthalmology, Gachon University College of Medicine, Gil Medical Center, 1198, Guwol-dong, Namdong-Gu, Incheon, 21565, KoreaEmail amidfree@gmail.comPurpose: To compare the short-term therapeutic effects of topical corticosteroids in patients with refractory dry eye disease (DED) according to the tear matrix metalloproteinase 9 (MMP-9) point-of-care positivity.Methods: This study was conducted on 137 patients who were referred from other eye clinics, complaining of irresponsive DED or acute DED flares despite routine treatment with topical cyclosporin or diquafosol. The patients received treatment with topical corticosteroids for 1 month. DED was evaluated by SANDE (Symptom Assessment in Dry Eye) questionnaire, tear film breakup time, ocular surface staining score, and meibomian gland dysfunction stage. The InflammaDry MMP-9 immunoassay was conducted in more symptomatic eyes of all patients. The changes in the subjective symptoms were additionally surveyed as symptom improvement score.Results: The mean age of the patients was 57.8± 13.4 years, and the tear MMP-9 positivity was 73.0%. Topical corticosteroids treatment showed significant improvement of symptoms and signs in the patients with refractory DED irrespective of the positivity of MMP-9 (each p< 0.001). The changes in SANDE score and OSS, and symptom improvement score were higher in the MMP-9 positive group than in the MMP-9 negative group (p=0.002/0.010/0.011). The overall rates of subjective symptoms improvement and SANDE reduction were 73.0% and 90.6% after topical corticosteroids treatment, respectively.Conclusion: Short-term topical corticosteroids had excellent therapeutic effects in patients with refractory DED or acute DED flares, irrespective of the tear MMP-9 level. Tear MMP-9 positivity may serve as a reliable response predictor of topical corticosteroids treatment in DED.Keywords: dry eye disease, ocular surface inflammation, tear MMP-9 positivity, corticosteroidRyu KJKim SKim MKPaik HJKim DHDove Medical Pressarticledry eye diseaseocular surface inflammationtear mmp-9 positivitycorticosteroidOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 759-767 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	dry eye disease ocular surface inflammation tear mmp-9 positivity corticosteroid Ophthalmology RE1-994
spellingShingle	dry eye disease ocular surface inflammation tear mmp-9 positivity corticosteroid Ophthalmology RE1-994 Ryu KJ Kim S Kim MK Paik HJ Kim DH Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
description	Kyung Jae Ryu,1 Seunghoon Kim,2 Mee Kum Kim,3 Hae Jung Paik,1 Dong Hyun Kim1 1Department of Ophthalmology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea; 2RudaCure Co., LTD, Incheon, Korea; 3Department of Ophthalmology, Seoul National University College of Medicine, Seoul, KoreaCorrespondence: Dong Hyun KimDepartment of Ophthalmology, Gachon University College of Medicine, Gil Medical Center, 1198, Guwol-dong, Namdong-Gu, Incheon, 21565, KoreaEmail amidfree@gmail.comPurpose: To compare the short-term therapeutic effects of topical corticosteroids in patients with refractory dry eye disease (DED) according to the tear matrix metalloproteinase 9 (MMP-9) point-of-care positivity.Methods: This study was conducted on 137 patients who were referred from other eye clinics, complaining of irresponsive DED or acute DED flares despite routine treatment with topical cyclosporin or diquafosol. The patients received treatment with topical corticosteroids for 1 month. DED was evaluated by SANDE (Symptom Assessment in Dry Eye) questionnaire, tear film breakup time, ocular surface staining score, and meibomian gland dysfunction stage. The InflammaDry MMP-9 immunoassay was conducted in more symptomatic eyes of all patients. The changes in the subjective symptoms were additionally surveyed as symptom improvement score.Results: The mean age of the patients was 57.8± 13.4 years, and the tear MMP-9 positivity was 73.0%. Topical corticosteroids treatment showed significant improvement of symptoms and signs in the patients with refractory DED irrespective of the positivity of MMP-9 (each p< 0.001). The changes in SANDE score and OSS, and symptom improvement score were higher in the MMP-9 positive group than in the MMP-9 negative group (p=0.002/0.010/0.011). The overall rates of subjective symptoms improvement and SANDE reduction were 73.0% and 90.6% after topical corticosteroids treatment, respectively.Conclusion: Short-term topical corticosteroids had excellent therapeutic effects in patients with refractory DED or acute DED flares, irrespective of the tear MMP-9 level. Tear MMP-9 positivity may serve as a reliable response predictor of topical corticosteroids treatment in DED.Keywords: dry eye disease, ocular surface inflammation, tear MMP-9 positivity, corticosteroid
format	article
author	Ryu KJ Kim S Kim MK Paik HJ Kim DH
author_facet	Ryu KJ Kim S Kim MK Paik HJ Kim DH
author_sort	Ryu KJ
title	Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
title_short	Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
title_full	Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
title_fullStr	Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
title_full_unstemmed	Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
title_sort	short-term therapeutic effects of topical corticosteroids on refractory dry eye disease: clinical usefulness of matrix metalloproteinase 9 testing as a response prediction marker
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/ca31216df33c41b39e8b182d6b17ba52
work_keys_str_mv	AT ryukj shorttermtherapeuticeffectsoftopicalcorticosteroidsonrefractorydryeyediseaseclinicalusefulnessofmatrixmetalloproteinase9testingasaresponsepredictionmarker AT kims shorttermtherapeuticeffectsoftopicalcorticosteroidsonrefractorydryeyediseaseclinicalusefulnessofmatrixmetalloproteinase9testingasaresponsepredictionmarker AT kimmk shorttermtherapeuticeffectsoftopicalcorticosteroidsonrefractorydryeyediseaseclinicalusefulnessofmatrixmetalloproteinase9testingasaresponsepredictionmarker AT paikhj shorttermtherapeuticeffectsoftopicalcorticosteroidsonrefractorydryeyediseaseclinicalusefulnessofmatrixmetalloproteinase9testingasaresponsepredictionmarker AT kimdh shorttermtherapeuticeffectsoftopicalcorticosteroidsonrefractorydryeyediseaseclinicalusefulnessofmatrixmetalloproteinase9testingasaresponsepredictionmarker
_version_	1718391218914721792

Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker

Ejemplares similares